A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)
Condition(s):Pneumococcal InfectionsLast Updated:November 2, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Pneumococcal InfectionsLast Updated:November 2, 2021Completed
Condition(s):Pneumococcal InfectionsLast Updated:April 16, 2019Completed
Condition(s):Pneumococcal InfectionsLast Updated:July 26, 2022Completed
Condition(s):Pneumococcal InfectionLast Updated:October 30, 2018Completed
Condition(s):Pneumococcal DiseaseLast Updated:January 31, 2024Recruiting
Condition(s):Pneumococcal InfectionLast Updated:October 2, 2018Completed
Condition(s):Pneumococcal InfectionsLast Updated:April 2, 2019Completed
Condition(s):Pneumococcal InfectionsLast Updated:April 20, 2020Completed
Condition(s):Pneumococcal InfectionsLast Updated:January 27, 2016Completed
Condition(s):Pneumococcal InfectionsLast Updated:November 2, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.